Loading
JPXHealthcareMedical - Distribution
Latest quote
¥2,292
+¥7.50 · +0.33%
Alfresa Holdings Corporation, a Japanese company established in Tokyo in 2003, operates globally through its subsidiaries, specializing in the production, wholesale distribution, marketing, and international trade of pharmaceuticals, diagnostic reagents, and medical equipment. A significant part of its operations involves the wholesale supply of ethical pharmaceuticals, diagnostic reagents, and medical devices to healthcare providers including hospitals, clinics, and dispensing pharmacies. The company also manages the wholesale distribution of self-medication products, such as over-the-counter drugs, nutritional supplements, and health foods, to drugstores and pharmacies. Furthermore, Alfresa is engaged in the manufacturing and commercialization of active pharmaceutical ingredients, various pharmaceuticals, diagnostic reagents, and medical devices, alongside providing contract manufacturing services for pharmaceutical goods. Its medical-related division also encompasses the management of dispensing pharmacies and other associated healthcare activities.
Latest quote
¥2,292
+¥7.50 · +0.33%
Regular session · JST · Market data may be delayed.
Alfresa Holdings Corporation, a Japanese company established in Tokyo in 2003, operates globally through its subsidiaries, specializing in the production, wholesale distribution, marketing, and international trade of pharmaceuticals, diagnostic reagents, and medical equipment. A significant part of its operations involves the wholesale supply of ethical pharmaceuticals, diagnostic reagents, and medical devices to healthcare providers including hospitals, clinics, and dispensing pharmacies. The company also manages the wholesale distribution of self-medication products, such as over-the-counter drugs, nutritional supplements, and health foods, to drugstores and pharmacies. Furthermore, Alfresa is engaged in the manufacturing and commercialization of active pharmaceutical ingredients, various pharmaceuticals, diagnostic reagents, and medical devices, alongside providing contract manufacturing services for pharmaceutical goods. Its medical-related division also encompasses the management of dispensing pharmacies and other associated healthcare activities.
52-week range
Current ¥2,292
Regular session · JST · Market data may be delayed.
Alfresa Holdings Corporation, a Japanese company established in Tokyo in 2003, operates globally through its subsidiaries, specializing in the production, wholesale distribution, marketing, and international trade of pharmaceuticals, diagnostic reagents, and medical equipment. A significant part of its operations involves the wholesale supply of ethical pharmaceuticals, diagnostic reagents, and medical devices to healthcare providers including hospitals, clinics, and dispensing pharmacies. The company also manages the wholesale distribution of self-medication products, such as over-the-counter drugs, nutritional supplements, and health foods, to drugstores and pharmacies. Furthermore, Alfresa is engaged in the manufacturing and commercialization of active pharmaceutical ingredients, various pharmaceuticals, diagnostic reagents, and medical devices, alongside providing contract manufacturing services for pharmaceutical goods. Its medical-related division also encompasses the management of dispensing pharmacies and other associated healthcare activities.
52-week range
Current ¥2,292
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 3.1T JPY | 2.96T JPY | 2.86T JPY | 2.7T JPY | 2.59T JPY |
| Cost of goods sold | 2.89T JPY | 2.76T JPY | 2.66T JPY | 2.51T JPY | 2.41T JPY |
| Gross profit | 217.88B JPY | 202.71B JPY | 196.36B JPY | 182.26B JPY | 178.31B JPY |
| Research and development | — | 1.9B JPY | 2.2B JPY | 2.09B JPY | 1.37B JPY |
| Selling, general, and administrative | 181.86B JPY | 162.54B JPY | 155.7B JPY | 150.02B JPY | 147.85B JPY |
| Operating expenses | 181.86B JPY | 164.44B JPY | 157.9B JPY | 152.11B JPY | 149.22B JPY |
| Interest income | 376M JPY | 144M JPY | 59M JPY | 56M JPY | 64M JPY |
| Interest expense | 354M JPY | 279M JPY | 132M JPY | 64M JPY | 73M JPY |
| Depreciation and amortization | 15.05B JPY | 14.92B JPY | 13.51B JPY | 13.3B JPY | 12.82B JPY |
| Operating income | 36.02B JPY | 38.27B JPY | 38.46B JPY | 30.15B JPY | 29.09B JPY |
| Net income | 41.75B JPY | 27.39B JPY | 29.56B JPY | 25.79B JPY | 32.18B JPY |
Company facts updated Sep 9, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T1.19B0.04%2.92T JPY0.05%¥414.9-0.22%
Avantis International Small Cap Value ETFAVDV38.1M0.18%20.51B USD0.36%$111.88-0.43%
Vanguard Total International Stock ETFVXUS37.65M0.01%646.2B USD0.05%$87.475-0.69%
Vanguard FTSE Developed Markets ETFVEA24.06M0.01%315B USD0.03%$72.885-0.77%
iShares Core MSCI EAFE ETFIEFA17.28M0.01%196.63B USD0.07%$99.445-1.04%
iShares MSCI EAFE Small-Cap ETFSCZ8.58M0.07%13.23B USD0.40%$86.135-0.80%
Dimensional - International Small Cap Value ETFDISV7.32M0.14%5.29B USD0.42%$44.40-0.52%
Avantis International Equity ETFAVDE6.26M0.03%19.18B USD0.23%$93.03-0.70%iShares Core TOPIX ETF1475.TAvantis International Small Cap Value ETFAVDVVanguard Total International Stock ETFVXUSVanguard FTSE Developed Markets ETFVEAiShares Core MSCI EAFE ETFIEFAiShares MSCI EAFE Small-Cap ETFSCZDimensional - International Small Cap Value ETFDISVAvantis International Equity ETFAVDEAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
